Navigation Links
Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference
Date:1/4/2011

PRINCETON, N.J., Jan. 4, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the 29th Annual J.P. Morgan Healthcare Conference to be held January 10-13, 2011 at the Westin St. Francis Hotel, San Francisco, CA. Schaefer Price, President and Chief Executive Officer, will provide an overview of the company on Wednesday, January 12, 2011 at 9:00 AM (PT).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About PharmassetPharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis C virus (HCV). Our research and development efforts focus on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. We currently have four clinical-stage product candidates. RG7128, a cytosine nucleoside analog for chronic HCV infection, is in tw
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... -- In accordance with Rule 17.1 and Rule 2.9 of ... States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today ... ELN). Background On 2 May 2013, ... the entire of the issued and to be issued share ... On 20 May 2013, Royalty Pharma announced the ...
(Date:5/23/2013)... SHENYANG, CHINA , May 24, 2013 /PRNewswire/ ... ("3SBio" or the "Company"), a leading ... developing, manufacturing and marketing biopharmaceutical products, announced today ... (the "EGM"), the Company,s shareholders voted in favor ... previously announced agreement and plan of merger dated ...
(Date:5/23/2013)... Amgen (NASDAQ: AMGN ) will present ... on Thursday, May 30, 2013, at the Westin Boston Waterfront ... Eastern Daylight Time. Arvind Sood , vice ... conference. Live audio of the presentation can be accessed from ... Investors. A replay of the webcast will also be available ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 93SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... Oct. 3, 2011 To help frustrated nighttime nasal ... chronic nasal congestion and trouble with sleep, the makers ... to identify the 20 Most Congested Cities in the ... metropolitan areas where residents are most challenged by congestion ...
... MURRIETA, Calif., Oct. 3, 2011 ... recently took delivery of their long-awaited WASP® (Walk ... Module.  The acquisition was concomitant with the inauguration ... ongoing efforts to optimize patient care by consolidating ...
Cached Medicine Technology:20 Most Congested Cities in U.S. Unveiled 220 Most Congested Cities in U.S. Unveiled 320 Most Congested Cities in U.S. Unveiled 4COPAN WASP® Lands at Prestigious Boston Medical Center 2COPAN WASP® Lands at Prestigious Boston Medical Center 3
(Date:5/25/2013)... NY (PRWEB) May 25, 2013 On May ... many people do not wish to discuss or plan for ... life. FuneralFinancials.com released a Must-Do List to ... 1. Funeral Financials recommends, “Creating a personal fact sheet.” , ... to organize financial information and personal data. It may ...
(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...
(Date:5/25/2013)... Many orthodontists have thought about moving their office to ... Most people would naturally assume that the company ... service and support would own and maintain all the ... be wrong. Cloud providers lease space in a ... houses servers and related equipment to run cloud environments) ...
(Date:5/25/2013)... Plains, NJ (PRWEB) May 25, 2013 ... iPhone. The universal app version of Word Hunt ... app versions of Concentration, Edge Match, Flash 2, Sudoku and ... , The brain games’ gameplay and revolutionary lifetime brain fitness ... 4 inch displays. , “100 years of brain fitness measurement ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Prairie ... community, is hosting an American Red Cross Blood Drive ... , The community, which is located at 955 Villa ... incomes, including those on Medicaid, who need some help ... Gift of Life," says Andrea Arview Frey, Director of ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Acuity Games Apps Come to the iPhone 2Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2
... Mayo Clinic, whether inhaled corticosteroids can treat a patient's chronic ... simple, fast and economical test; asthma breath test.// ... chronic cough. Postnasal drip syndrome, asthma and gastroesophageal reflux are ... sometimes caused by non-asthmatic eosinophilic bronchitis. ,The exhaled ...
... specialist, women in their early 30s, who want to have ... eggs.// ,As several women seem to have kids ... the British Fertility Society.,“This can be because they have focused ... found "Mr Right",” she said. ,However, this proposal ...
... fearful situation can play an important role in inspiring ... while conducting a more in-depth research// on the formation ... the very anticipation of a fearful situation can stir ... the event has occurred. ,The researchers explained ...
... A three-month detection program in Myanmar has found no new ... ,The country of Myanmar has declared a victory ... virus detected since April last year, according to the official ... health body OIE on Monday it was free of the ...
... A new study in JAMA, The Journal of the ... new doctors work as hard as ever. Doctors' training, ... although rules framed by Accreditation Council for Graduate Medical ... ,Christopher Landrigan, MD, MPH, of Harvard Medical ...
... they were fully prepared to deal with an outbreak of ... being detected// in the city. ,"We have not ... the disease is quite similar to that of dengue, necessary ... said N.K. Yadav, additional municipal health officer of Delhi. ...
Cached Medicine News:Health News:Asthma Breath Test in Diagnosis of Chronic Cough 2Health News:Women delaying motherhood 'should freeze eggs' 2Health News:Anticipation Could Have An Intense Effect On Memory 2Health News:Anticipation Could Have An Intense Effect On Memory 3Health News:Myanmar Declares Herself As A Country Free of Bird flu 2Health News:Delhi Gears up to Fight Chikungunya Fever 2
... Using the latest in solid-state technology, ... green light at 532 nm. Patented ... delivery device options maximize versatility, compact ... and advanced design minimizes any routine ...
... expensive of the series. It has the ability to ... the cornea. The model comes with a 9 high-resolution ... a patients corneal endothelium, you simply ask the patient ... rest. The left side of the chin rest allows ...
The simplest, most accurate Ortho-K lens fitting system ever!...
... The Euclid Systems Orthokeratology (oprifocon ... permeable contact lenses used for orthokeratology, ... (myopia). The patient wears these lenses ... morning. During the day, nearsightedness is ...
Medicine Products: